Literature DB >> 19782768

Fine tuning T lymphocytes: a role for the lipid phosphatase SHIP-1.

Richard V Parry1, Stephanie J Harris, Stephen G Ward.   

Abstract

The phosphoinositide 3-kinase signaling pathway regulates a range of T lymphocyte cellular functions including growth, proliferation, cytokine secretion and survival. Aberrant regulation of phosphoinositide 3-kinase-dependent signaling in T lymphocytes has been implicated in inflammatory and autoimmune diseases. In common with much of the immune system, several mechanisms exist to ensure the pathway is tightly regulated to elicit appropriate responses. One level of control involves the Src homology 2 domain-containing inositol-5-phosphatase-1 (SHIP-1) that modulates phosphoinositide 3-kinase signaling by degrading the key signaling lipid PI(3,4,5)P(3) to PI(3,4)P(2), but also serves as a key scaffolding molecule in the formation of multi-protein complexes. Here we discuss the role of SHIP-1 in regulating T lymphocyte and immune function, as well as its potential as a therapeutic target. Copyright 2009 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19782768     DOI: 10.1016/j.bbapap.2009.09.019

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  11 in total

Review 1.  Signaling in lymphocyte activation.

Authors:  Doreen Cantrell
Journal:  Cold Spring Harb Perspect Biol       Date:  2015-06-01       Impact factor: 10.005

Review 2.  Purinergic regulation of the immune system.

Authors:  Caglar Cekic; Joel Linden
Journal:  Nat Rev Immunol       Date:  2016-03       Impact factor: 53.106

Review 3.  PI3Ks in lymphocyte signaling and development.

Authors:  Klaus Okkenhaug; David A Fruman
Journal:  Curr Top Microbiol Immunol       Date:  2010       Impact factor: 4.291

Review 4.  Molecular control of PtdIns(3,4,5)P3 signaling in neutrophils.

Authors:  Hongbo R Luo; Subhanjan Mondal
Journal:  EMBO Rep       Date:  2015-01-09       Impact factor: 8.807

5.  Characterization of AQX-1125, a small-molecule SHIP1 activator: Part 1. Effects on inflammatory cell activation and chemotaxis in vitro and pharmacokinetic characterization in vivo.

Authors:  Grant R Stenton; Lloyd F Mackenzie; Patrick Tam; Jennifer L Cross; Curtis Harwig; Jeffrey Raymond; Judy Toews; Joyce Wu; Nancy Ogden; Thomas MacRury; Csaba Szabo
Journal:  Br J Pharmacol       Date:  2013-03       Impact factor: 8.739

6.  Phosphoinositide lipid phosphatase SHIP1 and PTEN coordinate to regulate cell migration and adhesion.

Authors:  Subhanjan Mondal; Kulandayan K Subramanian; Jiro Sakai; Besnik Bajrami; Hongbo R Luo
Journal:  Mol Biol Cell       Date:  2012-02-09       Impact factor: 4.138

7.  Downregulation of inhibitory SRC homology 2 domain-containing phosphatase-1 (SHP-1) leads to recovery of T cell responses in elderly.

Authors:  Aurélie Le Page; Carl Fortin; Hugo Garneau; Nancy Allard; Krassimira Tsvetkova; Crystal Tze Ying Tan; Anis Larbi; Gilles Dupuis; Tamas Fülöp
Journal:  Cell Commun Signal       Date:  2014-01-09       Impact factor: 5.712

Review 8.  Intracellular B Lymphocyte Signalling and the Regulation of Humoral Immunity and Autoimmunity.

Authors:  Taher E Taher; Jonas Bystrom; Voon H Ong; David A Isenberg; Yves Renaudineau; David J Abraham; Rizgar A Mageed
Journal:  Clin Rev Allergy Immunol       Date:  2017-10       Impact factor: 8.667

9.  Inhibition of lipid phosphatase SHIP1 expands myeloid-derived suppressor cells and attenuates rheumatoid arthritis in mice.

Authors:  Eui-Young So; Changqi Sun; Keith Q Wu; Patrycja M Dubielecka; Anthony M Reginato; Olin D Liang
Journal:  Am J Physiol Cell Physiol       Date:  2021-07-21       Impact factor: 5.282

Review 10.  Beyond the Cell Surface: Targeting Intracellular Negative Regulators to Enhance T cell Anti-Tumor Activity.

Authors:  Poojitha Sitaram; Bradley Uyemura; Subramaniam Malarkannan; Matthew J Riese
Journal:  Int J Mol Sci       Date:  2019-11-20       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.